Dicellasp. z o.o.
Research and experimental development in natural sciences and engineering
Overview
Dicella is a team of software developers specializing in electronic data capture for clinical trials, offering products such as eCRF, CTMS, eISF/eTMF, and IWRS. They also incorporate technologies like blockchain and artificial intelligence to enhance data protection and support researchers throughout the clinical trial process.
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2018-01-05. Active
19 1240 4432 1111 0010 8760 8185- 44 1240 1444 1111 0010 7713 0751
- 62 1240 4432 1111 0010 7876 1884
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Mar 11, 2019 | Call to creditors |
Public aid
32 public aid cases recorded, with a total value of $1,186,162.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 11, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $27,727$27,727 | Fundacja Klaster Lifescience Kraków | |
| Dec 3, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $303$303 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Apr 14, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $0$0 | Prezes Zakładu Ubezpieczeń Społecznych |
European Funds
5 projects co-financed from European Funds recorded, with total EU co-financing of $931,172.
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2022-01-01 | eCRF+ML diCELLa clinical trials - elektroniczna karta pacjenta wsparta algorytmami uczenia maszynowego | $329.9K$329,862 | Program Operacyjny Inteligentny Rozwój | |
| 2020-09-01 | qCELLa- przeprowadzenie prac badawczo-rozwojowych w zakresie analizy zdjęć medycznych z wykorzystaniem komputerów kwantowych. | $482.3K$482,297 | Regionalny Program Operacyjny Województwa Małopolskiego na lata 2014-2020 | |
| 2020-01-07 | diCELLa R&D: Budowa centrum badawczo-rozwojowego umożliwiającego rozwój innowacyjnych produktów opartych o sztuczną inteligencje | $47,564$47,564 | Regionalny Program Operacyjny Województwa Małopolskiego na lata 2014-2020 |
Tenders
5 tenders recorded as contractor: 3 national ($135,034) and 2 EU ($248,514).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| May 26, 2026 | Zakup, dostawa i wdrożenie systemu informatycznego do zarządzania badaniami klinicznymi (CTMS) oraz zakup dodatkowych licencji systemu AMMS wraz z wdrożeniem. | $124.3K$124,257 | Szpital Kliniczny Ministerstwa Spraw Wewnętrznych i Administracji z Warmińsko-Mazurskim Centrum Onkologii w Olsztynie | |
| May 21, 2026 | Zakup, dostawa i wdrożenie systemu informatycznego do zarządzania badaniami klinicznymi (CTMS) oraz zakup dodatkowych licencji systemu AMMS wraz z wdrożeniem. | $124.3K$124,257 | Szpital Kliniczny Ministerstwa Spraw Wewnętrznych i Administracji z Warmińsko-Mazurskim Centrum Onkologii w Olsztynie | |
| Jul 21, 2025 | Dostawa, wdrożenie, świadczenie serwisu gwarancyjnego kreatora elektronicznego dzienniczka pacjenta (kreatora EDP) do zdalnego gromadzenia danych w badaniu klinicznym. | $36,628$36,628 | Uniwersytet Medyczny w Łodzi |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, the joint action of two members of the management board, or one member of the management board jointly with a commercial proxy, is required to submit declarations of will concerning the rights and obligations.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Aleksandra Kubica Misztal (40) | 950 | $12,830.90 | 39.0625% |
Krzysztof Paweł Misztal (41) | 950 | $12,830.90 | 39.0625% |
Voxel S.A. | 532 | $7,185.31 | 21.875% |
Aleksandra Kubica Misztal and Krzysztof Paweł Misztal hold a combined 78.1% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights | |
|---|---|---|
Jarosław Furdal (60)  | Other natural person. | |
Aleksandra Kubica-Misztal (40) | Shareholder of a limited liability company, 2500.0 PLN | |
Krzysztof Paweł Misztal (41) | Shareholder of a limited liability company, 2500.0 PLN | |
Grzegorz Rutkowski (58) | Other natural person. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| CTI Clinical Trial And Consulting Services Polandsp. z o.o. | $527,145.56 | ctifacts.com | ||
| Digital Pathology Team Witold Reznersp. k. | $383,078.99 | digitalpathologyteam.com | ||
| DigitmedS.A. | $382,907.91 | digitmed.pl | ||
| CCTSsp. z o.o. | $281,193.31 | ccts.pl | ||
| Createcsp. z o.o. | $250,174.08 | createc.com.pl | ||
| TCIsp. z o.o. | $218,471.87 | tci.pl | ||
| Codeit4us Rndsp. z o.o. | $152,435.96 | codeit4us.com | ||
| Pharmaxi Polandsp. z o.o. | $152,292.34 | pharmaxi.com.ua | ||
| AI Corelabsp. z o.o. | $128,365.55 | aicorelab.com | ||
| IntelliseqS.A. | $111,419.60 | intelliseq.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-06-05 | Share capital change (6,400.00 PLN → 121,600.00 PLN) | |
| 2025-06-05 | PKD change (Removed: 62, 72.19.Z, 85.59.B; Added: 62.10.B, 72.10.Z, 85.59.D) | |
| 2021-06-21 | Address change (Ul. Rakowicka 5/5, 31-511, Kraków → Ul. Podole 60, 30-394, Kraków) | |
| 2019-09-20 | Address change (Ul. Helclów 23/20, 31-148, Kraków → Ul. Rakowicka 5/5, 31-511, Kraków) | |
| 2019-07-04 | Share capital change (7,300.00 PLN → 6,400.00 PLN) |
FAQ
Last updated: 2026-07-22